2009 studies found for:    "Genital Diseases, Female" | United States
Show Display Options
Rank Status Study
1 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
2 Completed
Has Results
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
3 Unknown  LANDA Embryo Freezing Technique.
Conditions: Primary Infertility;   Secondary Infertility;   Genital Diseases, Male;   Genital Diseases, Female
Intervention:
4 Recruiting Prognostic Markers of Gynecologic Cancers
Conditions: Gynecologic Disease;   Gynecologic Cancer
Intervention:
5 Recruiting Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients
Conditions: Laparotomy;   Gynecologic Diseases
Intervention: Other: Enhanced recovery protocol
6 Withdrawn Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy
Condition: Gynecologic Diseases
Interventions: Procedure: Laparoscopic supracervical hysterectomy;   Procedure: Total laparoscopic hysterectomy
7 Completed
Has Results
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
Conditions: Esophageal Diseases;   Gastrointestinal Diseases;   Disorder of the Genitourinary System;   Gynecologic Diseases;   Kidney Diseases;   Liver Diseases;   Pancreatic Diseases;   Prostate Cancer;   Spinal Disease
Interventions: Device: Vigileo Monitor;   Device: FloTrac Sensor
8 Enrolling by invitation Novel Topical Therapies for the Treatment of Genital Pain
Condition: Female Genital Diseases
Interventions: Drug: Amitriptyline;   Drug: Baclofen;   Drug: Ketoprofen;   Drug: Ketamine;   Drug: Loperamide;   Drug: Gabapentin;   Drug: placebo
9 Recruiting Biomarkers for Gynecologic Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Benign Gynecological Disease
Intervention:
10 Completed Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting
Condition: Infertility
Intervention:
11 Completed
Has Results
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
12 Recruiting Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
13 Recruiting Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole
Condition: Bacterial Vaginosis
Intervention: Drug: SYM-1219
14 Recruiting A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Drug: SYM-1219;   Drug: Placebo
15 Recruiting A Study of Niraparib in Patients With Ovarian Cancer Who Have Received at Least Three Previous Chemotherapy Regimens
Condition: Ovarian Cancer
Intervention: Drug: Niraparib
16 Recruiting Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Conditions: Fallopian Tube Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Other: Comprehensive Geriatric Assessment;   Other: Questionnaire Administration
17 Recruiting Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Clear Cell Adenocarcinoma;   Ovarian Clear Cell Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis
18 Completed Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Neuropathy;   Neurotoxicity Syndrome;   Pain;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer
Interventions: Drug: Carboplatin;   Drug: Glutathione;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Other: Quality-of-Life Assessment
19 Recruiting Olaparib Treatment in Relapsed Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Interventions: Drug: OLAPARIB;   Drug: Single agent chemotherapy
20 Enrolling by invitation Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Conditions: Cervical Neoplasms;   Human Papillomavirus
Interventions: Device: BD HPV Assay on Viper LT;   Procedure: Colposcopy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years